• Home
  • Technology
    • Big Data
    • IT Services
    • Cyber Security
    • Cloud
    • IOT
    • Networking
    • ERP
    • Robotics
    • Biotechnology
  • Industry
    • Healthcare
    • Retail
    • Telecom
    • Marketing
    • Mining & Metals
    • Banking & Finance
    • Legal
    • Food & Beverage
    • Energy
  • Magazines
    • 10 Most Innovative Healthcare Leaders to Watch 2022
    • 10 Best Influential Leaders to Watch 2022
    • 10 Best Companies of the Year 2022
    • Top 5 AR/VR Solution Providers to Know in 2022
    • 10 Best Innovative Companies to watch In 2022
    • 10 Best Companies of the Year 2021
  • Clients Speak
  • Our Clients
  • Press Release
  • Privacy Policy
  • Terms & Conditions
Facebook Twitter Instagram LinkedIn
  • About Us
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
Facebook Twitter Instagram LinkedIn
Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas
  • Home
  • Technology
    • Big Data
    • IT Services
    • Storage
    • Cyber Security
    • Cloud
    • IOT
    • Networking
    • Robotics
    • ERP
    • Biotechnology
  • Industry
    • Healthcare
    • Retail
    • Telecom
    • Marketing
    • Mining & Metals
    • Banking & Finance
    • Legal
    • Food & Beverage
    • Energy
    • Startup
  • Magazines
    • 10 Most Innovative Healthcare Leaders to Watch in the World 2022
    • 10 Best Influential Leaders to Watch 2022
    • 10 Best Companies of the Year 2022
    • Top 5 AR/VR Solution Providers in 2022
    • 10 Best Innovative Companies to watch in 2022
    • 10 Best Companies of the Year 2021
  • Clients Speak
  • Our Clients
  • Featured Leaders
  • Press Release
Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas
Home»Healthcare»Pfizer Inc. and BioNTech signed a $3.2 billion deal with the U.S. government
Healthcare

Pfizer Inc. and BioNTech signed a $3.2 billion deal with the U.S. government

Pfizer Inc. and their partner BioNTech made an announcement on Wednesday that they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine. They are also set to deliver the Vaccines by this summer’s last only.

What does the new $3.2 billion deal include?

According to Pfizer, the $3.2 billion deal includes supplies of a retooled omicron-adapted vaccine, pending regulatory clearance. Drugmakers have been developing vaccines to target the omicron variant that became dominant last winter. In the new deal, the average price per dose is over $30, a more than 50% increase from the $19.50 per dose the U.S. government paid in its initial contract with Pfizer. Some of the vaccines included in the contract will be embarked for adults and will be of single dose.

U.S. Department of Health and Human Services official Dawn O’Connell said in a statement, “We look forward to taking delivery of these new variant-specific vaccines and working with state and local health departments, pharmacies, healthcare providers, federally qualified health centers, and other partners to make them available in communities around the country this fall,”

Change of COVID-19 Boosters

U.S. Food and Drug Administration advisers on Tuesday recommended a change in the design of COVID-19 booster shots for this fall in order to combat more recently circulating variants of the coronavirus.

According to a report by Reuters, “The U.S. government has distributed close to 450 million doses of the Pfizer/BioNTech vaccine in the United States since it was first authorized in December 2020, according to data from the U.S. Centers for Disease Control and Prevention. Over 350 million of those doses have been administered.

Because the Biden administration was unable to line up more COVID-19 funding from Congress earlier this month, it was forced to reallocate $10 billion of existing funding to pay for additional vaccines and treatments.”

Related Posts

After Covid-19, FLU is the new primary respiratory illness in USA

December 26, 2022

FDA says yes to Covid-19 Vaccines for Young Children

July 5, 2022

Healthcare Technology shaping the medical field of the future

March 1, 2022

The Network Tech Needed to Support Patient Care from Anywhere

October 18, 2021

Leave A Reply Cancel Reply

Stay In Touch
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
Recent

Maisonette: Nurturing Parenting and Upgrading kids’ Lifestyle

November 10, 2022

East Side Games – Delivering Memorable Mobile Gaming Experience Successfully

November 10, 2022

MYLÉ: Combining Modern Design And Technology To Offer a Premium Vaping Experience

August 28, 2022

Ehotel: Acing Hospitality Service Wishing Travelers Bon-Voyage

May 1, 2022

Kyla Dufresne:- Converting Possibilities Into Reality Whilst Embracing Women

August 31, 2022

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

About Us

Corporate Leaders Magazine is one of the acclaimed monthly/quarterly business magazines in the country. We aim to cater to Business Owners and Entrepreneurship Enthusiasts of the country with disruptive entrepreneurship stories.

Facebook Twitter Instagram LinkedIn
Topics
  • Big Data
  • Cloud
  • IOT
  • Telecom
  • Tech News
Contact Info

5214F Diamond Hts Blvd Unit #1056, San Francisco, CA 94131, USA

Phone: +1(760)-284-3025

Email Us: info@corporateleadersmagazine.com

Latest Issue
dbf5675a-76a2-4eca-b687-4e19e37b64f2
Cover Featured (1) (1)
10 Best Companies of the Year 2022
b31b8176-d515-47b9-b2d2-c404b6d57e7f
5748f23d-3749-4574-a231-640e9d53100f
7058d2aa-6f76-4472-8cba-69e2a6a85c0d
10 Best Companies of the Year 2022
b31b8176-d515-47b9-b2d2-c404b6d57e7f
5748f23d-3749-4574-a231-640e9d53100f
7058d2aa-6f76-4472-8cba-69e2a6a85c0d
Copyright © 2023 Corporate Leaders Magazine LLC | All Rights Reserved